Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer

被引：0
|
作者：
Frederik A. Verburg
Uwe Mäder
Markus Luster
Heribert Hänscheid
Christoph Reiners
机构：
[1] University of Würzburg,Department of Nuclear Medicine
[2] University of Würzburg,Comprehensive Cancer Center Mainfranken
[3] RWTH University Hospital Aachen,Department of Nuclear Medicine
[4] University Hospital Giessen and Marburg,Department of Nuclear Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2015年 / 42卷
关键词：
Differentiated thyroid carcinoma; Complete remission; I Therapy; Paediatric cancer; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1390 / 1398
页数：8
相关论文
共 50 条
  • [21] Successful ablation with 131I in patients with differentiated thyroid cancer: can TNM staging system predict it?
    Rodriguez-Gasen, A.
    Vercher-Conejero, J.
    Suils-Ramon, J.
    Mora Salvado, J.
    Benitez Segura, A.
    Bajen Lazaro, M.
    Rubio-Alvarez, L.
    Gamez-Cenzano, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S608 - S608
  • [22] Influencing factors of the first 131I ablation therapy for children and adolescents differentiated thyroid cancer
    Lina, L.
    Tian, T.
    Bin, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S622 - S622
  • [23] FACTORS AFFECTING I-131 ABLATION OF THYROID REMNANT AFTER THYROIDECTOMY FOR DIFFERENTIATED THYROID-CANCER
    CECCARELLI, C
    MARTINO, E
    LIPPI, F
    GIANCHECCHI, D
    LUCHETTI, F
    BRACCI, E
    PINCHERA, A
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 46 - 46
  • [24] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [25] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [26] PREGNANCY AFTER TOTAL THYROIDECTOMY AND I-131 THERAPY FOR THYROID-CANCER
    PELIZZO, MR
    MANFE, AZ
    CASARA, D
    GIRELLI, ME
    BUSNARDO, B
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1981, 6 (05): : A24 - A24
  • [27] THYROID CANCER AFTER 131I THERAPY FOR THYROTOXICOSIS
    STAFFURTH, JS
    BRITISH JOURNAL OF RADIOLOGY, 1966, 39 (462): : 471 - +
  • [28] Clinical pathway of metabolic therapy with 131I in differentiated thyroid cancer
    Saiz, I. Blanco
    Apinaniz, E. Anda
    Arribas, J. Pineda
    Moreno, F. Caudepon
    Iglesias, A. Fernandez
    Jimenez, M. Huarte
    Munoz, A. I. de Miguel
    Aristorena, M. I. Irigoyen
    Girones, E. Goni
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (03): : 178 - 187
  • [29] Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy
    Hussain, Syed Zubair
    Zaman, Maseeh Uz
    Malik, Sarwar
    Ram, Nanik
    Asghar, Ali
    Rabbani, Unaib
    Aftab, Nida
    Islam, Najmul
    JOURNAL OF THYROID RESEARCH, 2014, 2014
  • [30] Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131I Ablation Therapy for Differentiated Thyroid Cancer
    Hasbek, Zekiye
    Turgut, Bulent
    Kilicli, Fatih
    Altuntas, Emine Elif
    Yucel, Birsen
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (06) : 2523 - 2527
12345